CHACO Study: Control of Arterial Hypertension in Colombian Patients
NCT04094714 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1100
Last updated 2019-09-23
Summary
Epidemiological study (cross-sectional study) in order to determine the patients who present an adequate control of the Blood Pressure (BP), in a population of Colombian patients diagnosed with Arterial Hypertension (AH) and who are under pharmacological treatment.
Conditions
Sponsors & Collaborators
-
Scandinavia Pharma
lead INDUSTRY
Principal Investigators
-
Javier Castillo, Dr · Scandinavia Pharma
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-06-27
- Primary Completion
- 2023-12-31
- Completion
- 2024-07-31
Countries
- Colombia
Study Locations
More Related Trials
-
A Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With Hypertension
NCT06671392 ·Status: COMPLETED ·Phase: PHASE3
-
Epidemiological Study In Hypertensive Patients: Assessment Of Risk Factors Prevalence And Of Patients' Management
NCT00709787 ·Status: COMPLETED
-
Cardiovascular Autonomic Control Evaluation Through Cardiac Frequency Variability in Hypertensive Patients
NCT02211248 ·Status: COMPLETED ·Phase: NA
-
Pharmacogenomic Evaluation of Antihypertensive Responses 2
NCT01203852 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of a Natural Ingredient on Blood Pressure
NCT03471533 ·Status: COMPLETED ·Phase: NA
-
Pharmacosurveillance and Pharmacogenetics of First-line Diuretics in Hypertension: The StayOnDiur Study
NCT00408512 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Chronotherapy on Blood Pressure - Time of Intake of Blood Pressure Lowering Drugs
NCT05322967 ·Status: RECRUITING ·Phase: NA
-
Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy
NCT00295542 ·Status: COMPLETED ·Phase: PHASE4
-
Neuroinflammation in Hypertension Study
NCT04478500 ·Status: UNKNOWN ·Phase: PHASE3
-
Repurposing Colchicine to Improve Vascular Function in Hypertension
NCT04303689 ·Status: COMPLETED ·Phase: NA
-
Vascular Responses to Sympathetic Activation and Altered Shear Rate: The Impact of Hypertension and Sodium Intake
NCT03558022 ·Status: COMPLETED ·Phase: NA
-
Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days Infusion
NCT00190788 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Rostafuroxin in the Treatment of Essential Hypertension
NCT00415038 ·Status: COMPLETED ·Phase: PHASE2
-
Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)
NCT04040634 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Essential Hypotension and Allostasis Registry
NCT02018497 ·Status: UNKNOWN
-
Efficacy and Safety of DWC202404 and DWC202314 in Patients With Hypertension
NCT06682000 ·Status: COMPLETED ·Phase: PHASE3
-
Sympathetic Activity and Cardiometabolic Complications
NCT04495231 ·Status: COMPLETED
-
Blood Pressure in the Emergency Department
NCT03954119 ·Status: COMPLETED
-
Longitudinal Follow-up Study in Two Chinese Hypertension Cohorts
NCT04471389 ·Status: UNKNOWN
-
Treatment of Hypertension in Primary Care in Spain
NCT00868881 ·Status: COMPLETED
-
Protocol for a Multicentre Survey of Patients With Treatment Resistant Hypertension
NCT03078244 ·Status: COMPLETED
-
Use of Impedance Cardiography and Applanation Tonometry for Prediction of the Antihypertensive Effect of Two Drugs
NCT03560804 ·Status: COMPLETED ·Phase: NA
-
Retrospective Survey for Patients With Hypertension and Diabetes Mellitus
NCT00681278 ·Status: COMPLETED
-
Hypertensive Treatment and Epidemiological Analyses
NCT00005501 ·Status: COMPLETED
-
Phase IIa Study of the Product QGC001 Compared With Placebo in Patients With Essential Hypertension
NCT02322450 ·Status: COMPLETED ·Phase: PHASE2